This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2010 Oct 1;33(10):889-90.

doi: 10.2165/11532480-000000000-00000.

Pharmacovigilance activities in Nepal

Subish Palaian, Mohamed Izham Mohamed Ibrahim, Pranaya Mishra, Kadir Alam, Pathiyil Ravi Shankar, Bhupendra Bahadur Thapa

PMID: 20812773
DOI: 10.2165/11532480-000000000-00000

Comment

Pharmacovigilance activities in Nepal

Subish Palaian et al. Drug Saf. 2010.

. 2010 Oct 1;33(10):889-90.

doi: 10.2165/11532480-000000000-00000.

Authors

Subish Palaian, Mohamed Izham Mohamed Ibrahim, Pranaya Mishra, Kadir Alam, Pathiyil Ravi Shankar, Bhupendra Bahadur Thapa

PMID: 20812773
DOI: 10.2165/11532480-000000000-00000

No abstract available

PubMed Disclaimer

Comment on

Pharmacovigilance activities in 55 low- and middle-income countries: a questionnaire-based analysis.
Olsson S, Pal SN, Stergachis A, Couper M. Olsson S, et al. Drug Saf. 2010 Aug 1;33(8):689-703. doi: 10.2165/11536390-000000000-00000. Drug Saf. 2010. PMID: 20635827

Similar articles

Pharmacovigilance: Importance, concepts, and processes.
Kumar A. Kumar A. Am J Health Syst Pharm. 2017 Apr 15;74(8):606-612. doi: 10.2146/ajhp151031. Epub 2017 Feb 24. Am J Health Syst Pharm. 2017. PMID: 28235869 No abstract available.
Pharmacovigilance: urgent need in midwestern region of Nepal.
Khanal S, Gyawali S, Kanodia R, Rathor RS. Khanal S, et al. Kathmandu Univ Med J (KUMJ). 2009 Oct-Dec;7(28):470. doi: 10.3126/kumj.v7i4.2776. Kathmandu Univ Med J (KUMJ). 2009. PMID: 20502096 No abstract available.
What do stakeholders think about pharmacovigilance?
Edwards IR, Graedon T. Edwards IR, et al. Drug Saf. 2010 Aug 1;33(8):619-21. doi: 10.2165/11539210-000000000-00000. Drug Saf. 2010. PMID: 20635819 No abstract available.
Pharmacovigilance for evaluating adverse drug reactions: value, organization, and methods.
Montastruc JL, Sommet A, Lacroix I, Olivier P, Durrieu G, Damase-Michel C, Lapeyre-Mestre M, Bagheri H. Montastruc JL, et al. Joint Bone Spine. 2006 Dec;73(6):629-32. doi: 10.1016/j.jbspin.2006.09.002. Epub 2006 Oct 12. Joint Bone Spine. 2006. PMID: 17110152 Review. No abstract available.
Pharmacovigilance: methods, recent developments and future perspectives.
Härmark L, van Grootheest AC. Härmark L, et al. Eur J Clin Pharmacol. 2008 Aug;64(8):743-52. doi: 10.1007/s00228-008-0475-9. Epub 2008 Jun 4. Eur J Clin Pharmacol. 2008. PMID: 18523760 Review.

See all similar articles

Cited by

Bibliometric analysis of adverse drug reactions and pharmacovigilance research activities in Nepal.
Shrestha S, Danekhu K, Kc B, Palaian S, Ibrahim MIM. Shrestha S, et al. Ther Adv Drug Saf. 2020 Jun 12;11:2042098620922480. doi: 10.1177/2042098620922480. eCollection 2020. Ther Adv Drug Saf. 2020. PMID: 32587678 Free PMC article.

References

1. Drug Saf. 2010 Aug 1;33(8):689-703 - PubMed

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Springer
Medical
- MedlinePlus Health Information